• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Gotta Catch Them All! The Pokemon Approach to Understanding Direct Oral Anticoagulants

Program Type

OnDemand

Credits

1 Contact Hour(s)

Release Date

Thursday, September 27, 2018

Offline Date:

Saturday, March 27, 2021

ACPE Expiration Date

Saturday, March 27, 2021

Target Audience

Nurse, Pharmacist

Cost

$4.00

  • Overview

    Direct oral anticoagulants (DOACs) are recognized by guidelines as first-line options for the treatment of venous thromboembolism and prevention of stroke and systemic embolism in nonvalular atrial fibrillation. Now that multiple DOACs have been FDA approved for these indications, and their use is wide-spread, it is challenging to ensure patient safety as each agent has slightly different pharmacokinetic considerations with its use. This program will address safety and efficacy with each agent, initial recommendations for dosing and adjustments based on renal considerations, drug interactions, and age and weight. Common risk factors for bleeding will be identified as well as options in support of the management of bleeding, if it should occur, are proposed

    Handouts

    Slide Document:   18046H01_4pp.pdf
    Slide Document:   18046H01_2pp.pdf

    Financial Support By

    PharmCon, Inc.
  • Nurse

    Differentiate among the pharmacotherapeutic options available for the treatment of non-valvular atrial fibrillation and venous thromboembolism
    Apply knowledge of clinical trial data and guidelines in order to determine the most appropriate anticoagulant for individualized patients
    Based on risks for bleeding and other risk characteristics, recommend appropriate modifications and dose adjustments of direct oral anticoagulants


    Pharmacist

    Differentiate among the pharmacotherapeutic options available for the treatment of non-valvular atrial fibrillation and venous thromboembolism
    Apply knowledge of clinical trial data and guidelines in order to determine the most appropriate anticoagulant for individualized patients
    Based on risks for bleeding and other risk characteristics, recommend appropriate modifications and dose adjustments of direct oral anticoagulants

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-18-046-H01-N

    Pharmacist 0798-0000-18-046-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.